Keywords: Bristol-Myers Squibb, Pfizer, Eliquis, UK launch, Thromboembolic events, VTE

Bristol-Myers and Pfizer’s blood thinner Eliquis debuts in UK

Article | 21 September 2011

Print This

US drug majors Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) say that their Eliquis (apixaban), an oral treatment, is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in